Abstract
Trans* is an all-inclusive term that captures any individual with an internal gender identity that differs from the sex they were assigned at birth. These individuals can identify as the "opposite" gender (i.e., man or woman), as agender (i.e., genderfree, non-gender, genderless, or ungendered), as multiple genders (i.e., bigender or pangender), or as fluctuating genders (i.e., genderfluid or genderqueer). Many of these identities have recently evolved in conjunction with a greater societal understanding that gender identities fall along a spectrum, as opposed to a strict binary (female versus male). 1 Cisgender individuals, conversely, are those whose internal gender identity is congruent with the sex they were assigned at birth.
Transmen are defined as individuals who were assigned the female sex at
Proceedings in Obstetrics and Gynecology, 2015;5(2):3

Pregnant transmen and healthcare 2
birth, but identify with a masculine experience of gender. 2 Historically, a transman desiring medical means to affirm their gender has been referred to as a "female-to-male (FTM) transsexual." However, this designation reflected a binary gender system prior to the evolution of newly defined nonbinary gender identities. 3 The terms transman or trans* masculine allows for a diversity of experience within the community that at times includes the molding of the female/male gender binary into a gender spectrum.
To reflect this increased variability, many trans* individuals have adopted the term "affirm", as opposed to "transition", as it more accurately conveys a sense of becoming one's true self, as opposed to changing who one is.
2 The gender affirming process, and, by extension, the involvement of healthcare professionals, differs for each trans* individual. Cross-sex hormones, gender-affirming ("top"/"bottom") surgeries, pronoun/name changes, among other things are not a mandatory part of this process. 4 Hence, the extent of medical intervention is determined by however much is required to treat an individual's gender dysphoria.
Gender dysphoria replaced the term Gender Identity Disorder in the 2013 updated fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The diagnosis of gender dysphoria requires the presence of chronic distress and disability that trans* individuals often experience while living as a gender inconsistent with their internal gender identity. It is important to distinguish the difference between gender dysphoria and gender nonconformity. Gender non-conformity is a non-pathologic, normal variation in gender expression; it is not always accompanied by feelings of distress or dysphoria.
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Given that not all trans* individuals undergo gender-affirming surgeries including removal of their reproductive organs, healthcare providers must remain aware of the risk factors associated with a trans* individual's biological sex (e.g., breast and cervical cancer for transmen, prostate cancer for transwomen, etc.), along with an awareness of the health-related risks specifically associated with the trans* community. Furthermore, many choose to preserve their fertility. Transmen, specifically, can discontinue testosterone treatment, which may lead to a resumption of the ovulatory process and a return of fertility. The details of pregnancy in transmen, along with the associated healthcare delivery considerations will be discussed in greater detail below.
Estimates of the Trans* Population
A meta-analysis of 12 prevalence studies found the overall calculated prevalence of "transsexualism" was 4.6 in 100,000 individuals. 6 Many of the studies included in this meta-analysis, however, have been criticized for using inadequate surrogate variables. In response to these critics, one review study utilized mathematical models to account for the sampling errors, calculating that the overall prevalence of trans* individuals is likely between 1 in 500 to 1 12 Genetics, molecular abnormalities, and even gender identity have been excluded as causes of these increased rates; purporting that external forces, often termed minority stressors, are the principal etiology of most healthcare-related disparities. 13 Adolescents and young adults in the trans* population are disproportionately more likely to experience homelessness compared to their cisgender peers.
14 In addition, homeless trans* youth are exposed to a significantly greater number of health-related risks than homeless cisgender individuals.
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Disparities are also found in trans* individuals' personal relationships, reporting higher rates of intimate partner violence (34.6%) than any other group. 16 
Infrastructural Healthcare Inadequacies for the Care of Trans* Individuals
Social discrimination and minimal effort to provide culturally competent care has resulted in an infrastructure that is logistically unsuited for high-quality healthcare for trans* individuals. The World Professional Association for Transgender Health (WPATH), along with many other professional organizations, has highlighted and elaborated upon the inequity in care for the trans* population, and provided recommendations to address those inequities. 2, 5 In an attempt to make the implementation of these recommendations more realistic for healthcare organizations, many actionable guidelines have been published. [17] [18] [19] Additionally, federal law provides support for addressing the needs of trans* patients, and individual states are following this lead. Section 1101 of the Patient Protection and Affordable Care Act (PPACA, i.e., "Obamacare") mandates insurers to cover the treatment of gender dysphoria through the elimination of denying coverage based upon pre-existing conditions. 20 In 2013, Congress amended the federal code to mandate that all federally funded healthcare practitioners ensure trans* individuals are both receiving and getting insurance coverage for necessary preventive/screening
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procedures. 21 In May of 2014, the Department of Health and Human Services eliminated the automatic exclusion of gender-affirming surgery for Medicare beneficiaries to treat gender dysphoria. 22 As of August 2015, there are 6 states plus the district of Columbia that both ban insurance exclusion for transgender healthcare and provides transgender inclusive benefits for state employees. 23 With increasing insurance coverage and federal support for trans* care, it is critically important for primary care and Ob-Gyn providers to be aware of a patient's trans* identity regardless of whether gender identity is openly discussed during the patient-provider interaction. Unfortunately, the EMR may not make that information readily known. Logistically, EMRs across institutions differ vastly, but few make the adjustments necessary to accommodate trans* individuals. 24 A patient's legal gender is typically reflected in the medical record and oftentimes one of the demographic variables which determines certain functionalities. For trans* patients, this attempt to make the EMR more streamlined and less cumbersome, often results in obstructed access to key EMR features such as prostate screening for transwomen or obstetric care for transmen.
Recalcitrant discrimination and cultural insensitivity is the other chief fundamental barrier to providing highquality healthcare for trans* patients. A 2011 survey of greater than 6,000 trans* identifying patients found that 28 percent had postponed care when sick or injured, and 33 percent had not sought preventive care due to past experiences of gender-based discrimination. 25 A 2008 study of transmen found that while patients perceived preventive gynecologic care to be important, incorrect pronoun usage by medical staff and noninclusive health intake forms prevented transmen from receiving those services. 26 This disengagement from healthcare results in a greater burden of morbidity for easily treatable medical problems.
9
Obstetric Care for Transmen
What We Know About Perinatal Care for Transmen
In 2009, public attention was drawn to the image of Thomas Beatie, a transgender man whose pregnancy is described in his memoir, "Labor of Love". 27 There is, however, limited medical and nursing literature available describing the experience or health outcomes of pregnant transmen.
In accord with previous assumptions that all trans* persons desire to make complete anatomic "transitions" to the opposite gender, healthcare providers have historically presumed a permanent loss of fertility with the treatment of gender dysphoria. 28 While this scenario holds true for some trans* patients, there are many others whose affirmed gender does not include genderaffirming surgery and thus the patient retains natal reproductive organs. The medical community has not ascertained if there are genetic, epigenetic, or molecular changes to oocytes in response to long-term testosterone therapy. It is known that testosterone treatment may reduce fertility, though it
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is unknown whether this effect is universally fully reversible if testosterone is stopped. 29 Historically, recommendations have suggested that trans* individuals be offered the same opportunity to "bank" their gametes as would a fertile patient undergoing treatment for malignant disease. 30 Unfortunately, oocyte banking involves ovarian stimulation and egg retrieval, which may increase gender dysphoria and is often not covered by insurance and thus may be cost prohibitive.
As the concept of gender nonconformity has become more socially accepted, so too have the number of persons with stories similar to Thomas Beatie. Transmen with varying degrees of treatment for gender dysphoria have desired and achieved pregnancy, many within six months of discontinuing testosterone therapy. 31 While transmen seemingly can experience a return of fertility in addition to normal birth outcomes for pregnancies, the topic certainly deserves more investigation. Because of this lack of necessary data, it is still important to have a discussion regarding fertility preservation with gamete banking prior to initiation of testosterone in transmen.
While important to discuss fertility preservation, it is also critical to provide counseling regarding the possible ineffectiveness of testosterone as the sole method of contraception for those not desiring pregnancy. Many transmen receiving testosterone therapy stop ovulating and become amenorrheic within 3 months. However, ovulation suppression may not always occur and penile-vaginal intercourse may result in unwanted pregnancy.
This may be more commonplace in trans* masculine persons identifying as gender nonbinary and desiring a more androgynous physical appearance often achieved by receiving a low dose of testosterone, or transmen who miss doses of testosterone.
While research is limited, there are a number of small studies that detail obstetric care of transmen. A 2014 web based survey of 41 pregnant trans*masculine participants highlighted the complex interplay of emotions during this period. 31 Gender dysphoria was increased in some of the participants, while decreased in others. Interactions with providers varied amongst the participants, though it was notable that good interactions were marked by compassion, respect, genderappropriate language, and normalcy from the healthcare staff. Isolation was another theme that extended from limited transmen-specific resources, as well as feeling perceived lack of support. Participants also felt that the family structure was fundamentally altered in essential ways to create the patients preferred family. Some participants were apprehensive about those alterations, while others celebrated the change.
Similarly, another 2014 qualitative study details the experience of eight transmen and gender-variant gestational parents who had transitioned socially or medically before pregnancy. 32 Loneliness was a theme throughout the preconception, prenatal, and postpartum periods, at times exacerbated by forced disclosure of trans* status secondary to being pregnant. Participants had varied responses to the physical changes of pregnancy, which were welcome to
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some but not all. Tension points encountered with the healthcare system included discomfort and fear while building rapport with providers, communicating with office staff, receiving inpatient care in areas where patients are expected to appear female, accessing community resources, and being referred to outside providers. Participants did not want to overhear their gender identity being disclosed or discussed inappropriately.
Postpartum transmen commonly desire to chestfeed (i.e., breastfeed) though success rates may depend on previous surgical or medical treatment. Transmen with prior history of testosterone treatment may have lower rates of successful chestfeeding.
32 Surprisingly, chestfeeding may still be an option for transmen even if they have undergone male chest reconstruction. 31 This new subset of patients presents a number of unique considerations for lactation consultants and postpartum nursing. 33 Special attention should be paid to asking a patient's preferred anatomic terms and being ever mindful of pronouns. Additionally, it is important to be respectful of the spectrum of emotions that may be evoked by lactation in transmen, from an increase in gender dysphoria to experiencing a newfound connection with their natal bodies.
With an increasing number of transmen presenting for obstetric care, all healthcare staff involved in the peripartum period require sufficient education to create a culturally-sensitive and welcoming environment for trans* patients. No longer can assumptions be made regarding a pregnant patient's preferred pronouns, gender identity, or postpartum desire to nurse one's infant.
Recommendations
Electronic Medical Records
Transmen presenting for obstetric care and providers aspiring to provide such care are greeted by the immediate challenge of documenting the patient's pregnancy. Legal gender changes are often reflected in the EMR. This change may prevent healthcare staff from accessing features necessary to properly document obstetric care. Thus, proper documentation may require changing the patient's gender from "male" to "female," which can result in feelings of dysphoria and discomfort within the healthcare system. Similar themes exist for access to essential screening tests, as EMRs may restrict providers from ordering cervical pap smears and mammograms for patients designated as "male" in their chart.
The addition of a more detailed sex/gender component in the patient demographics area would be a proposed solution for this obstacle. This is most reliably obtained by using a twopart question regarding the patient's "assigned sex at birth" (ASAB) in addition to the patient's "self-identified gender." In this manner, a trans* person is differentiated from a cisgender person because the answer to question one differs from the answer to question two. For example, transmen will have an "ASAB: female" and may answer the question of "self-identified gender" in a variety of ways: "man," or "transman," or "non-binary." With this format, the EMR would have sufficient information to allow for streamlined access to necessary gender affirming-related features, in addition to features relating to the patient's ASAB.
In addition to accurate identification of a patient's sex and gender in the EMR, it is critically important to allow for documentation of preferred name. This functionality would benefit many patients, cisgender and transgender alike, who prefer to be called something different than their given name. Ideally, the preferred name as well as the patient's assigned sex at birth and selfidentified gender would be present in a visible location such as the patient header.
Staff Training
In 2015, the Fenway Institute outlined a framework for providing culturally competent care for gender minorities, highlighting appropriate language and the importance of avoiding unnecessary questions.
2 In order to assure that trans* patients receive high quality obstetric care in a welcoming environment, cultural competence education must be made a priority for the entire healthcare team, from front-line staff to nurses to licensed independent providers.
To make staff more familiar with appropriate language in order to provide culturally sensitive care to pregnant transmen, and to allow time to answer questions regarding general trans* health prior to the patient's delivery, our institution conducted two brief training sessions for staff members on the labor and delivery unit and the postpartum unit. These were led by a family physician that cares for transgender patients in a specialized clinic, and a nurse-midwife.
Knowledge of Resources for Trans* Families Experiencing Pregnancy and Parenthood
Lack of resources for pregnant and post-partum trans* masculine patients may be a factor contributing to feelings of isolation in this population. 30 It is prudent that providers working with trans* identified patients have knowledge about organizations available for peer and family support, mental health care including psychotherapy and on-going medical care. A list of resources, both local and national, can be found in Appendix A.
Conclusion
While trans* masculine patients face social and structural barriers to culturally appropriate care, obstetric providers have the opportunity and responsibility to improve individual and institutional readiness to meet the needs of trans* families in the perinatal period. Our efforts must be interdisciplinary, involving all staff who have face-to-face encounters with families, and those who can effect change of the EMR infrastructure necessary to provide safe, respectful care.
